A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies

Journal of Clinical Laboratory Analysis

Volumn 30, Issue 6, 2016, Pages 859-866

  Tampoia, Marilina ^a   Notarnicola, Antonella ^a   Abbracciavento, Letizia ^a   Fontana, Antonietta ^a   Giannini, Margherita ^a   Louis Humbel, Renè ^b   Iannone, Florenzo ^a  

^a POLICLINICO   (Italy)

^b Laboratoire Luxembougeois d'Immuno Pathologie   (Luxembourg)

Author keywords

idiopathic inflammatory myopathies; indirect immunofluorescence method; multiplex assays; myositis associated autoantibodies; myositis specific autoantibodies

Indexed keywords

AMINOACYL TRNA SYNTHETASE ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; JO 1 ANTIBODY; MI 2 ANTIBODY; SMALL UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ANTIBODY; TRANSCRIPTION INTERMEDIARY FACTOR 1 GAMMA ANTIBODY; UNCLASSIFIED DRUG; AMINO ACID TRANSFER RNA LIGASE; HISTIDINE TRANSFER RNA LIGASE; NUCLEAR PROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; MULTIPLEX IMMUNODOT ASSAY; MYOSITIS; POLYMYOSITIS; BLOOD; COHORT ANALYSIS; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; ITALY; MIDDLE AGED; PROCEDURES; SEROLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACYL-TRNA SYNTHETASES; AUTOANTIBODIES; COHORT STUDIES; FEMALE; HISTIDINE-TRNA LIGASE; HUMANS; IMMUNOLOGIC TESTS; ITALY; MALE; MIDDLE AGED; MYOSITIS; NUCLEAR PROTEINS; SEROLOGIC TESTS;

EID: 84963894164     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21948     Document Type: Article

References (32)

1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first part). N Engl J Med. 1975;292:344–347.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (second part). N Engl J Med. 1975;292:403–407.
3. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362:971–982.
4. Dalakas MC. Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011;37:226–242.
5. Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD. Inter relationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996;39:1507–1518.
6. Shamim EA, Rider LG, Miller FW. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2000;12:482–491.
7. Targoff IN. Autoantibodies and their significance in myositis. Curr Rheumatol Rep 2008;10:333–340.
8. Reichlin M, Arnett FCJr. Multiplicity of antibodies in myositis sera. Arthritis Rheum. 1984;27:1150–1156.
9. Brouwer R, Hengstman GJ, Vree Egberts W, et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001;60:116–123.
10. Betteridge ZE, Gunawardena H, North J. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 2011;13:209–215
11. Howard OM, Dong HF, Yang D, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002;196:781–791.
12. Eloranta ML, Barbasso Helmers S, Ulfgren AK, Rönnblom L, Alm GV, Lundberg IE. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro 60 autoantibodies. Arthritis Rheum 2007;56:3112–3124.
13. Ghirardello A, Bassi N, Palma L, Borella E, Domeneghetti M, Punzi L, Doria A. Autoantibodies in polymyositis and dermatomyositis. Curr Rheumatol Rep 2013;15:335–345.
14. Vincze M, Molnar PA, Tumpek J, et al. An unusual association: Anti-Jo-1 and anti-SRP antibodies in the serum of a patient with polymyositis. Clin Rheumatol 2010;29:811–814.
15. Sugie K, Tonomura Y, Ueno S. Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies. Int Med 2011;51:799–802.
16. Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Anti-Jo-1 antibodies. Autoimmunity. 2005;38:73–78.
17. Ghirardello A, Zampieri S, Iaccarino L, et al. Anti-Mi-2 antibodies. Autoimmunity 2005;38:79–83.
18. Hengstman GJD, Vree Egberts WT, Seelig HP, et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2β antigen. Ann Rheum Dis 2006;65:242–245.
19. Hengstman GJ, ter Laak HJ, Vree Egberts WT, et al. Anti-signal recognition particle autoantibodies: Marker of a necrotising myopathy. Ann Rheum Dis 2006;65:1635–1638.
20. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A. Cutting edge issues in polymyositis. Clin Rev Allergy Immunol 2011;41:179–189.
21. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen LA. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. J Am Acad Dermatol 2011;65:25–34.
22. Mammen AL, Chung T, Christopher-Stine L, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713–721.
23. Hengstman GJD, van Brenk L, Vree Egberts WTM, et al. High specificity of myositis specific autoantibodies for myositis compared with other neuromuscular disorders. J Neurol 2005;252:534–537.
24. Suzuki S, Satoh T, Sato S, et al. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford) 2008;47:1539–1542.
25. Altman DG and Bland JM. Diagnostic test1: Sensitivity and specificity. Br Med J 1994;308:1552.
26. Meroni PL, Schur PH. ANA screening: An old test with new recommendations. Ann Rheum Dis 2010;69:1420–1422.
27. Rönnelid J, Barbasso Helmers S, Storfors H, et al. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies. Autoimmun Rev 2009;9:58–61.
28. Ghirardello A, Bendo R. Rampudda ME, Bassi N, Zampieri S, Doria A. Commercial blot assay in the diagnosis of sistemic rheumatic diseases. Autoimmun Rev 2009;8:645–649
29. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73:17–23.
30. Hervier B, Benveniste O. Clinical heterogeneity and outcomes of antisynthetase syndrome. Curr Rheumatol Rep 2013;15:349–361.
31. Batteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum 2007;56:3132–3137.
32. Tarricone E, Ghirardello A, Rampudda M, Bassin, Punzi L, Doria A. Anti-SAE antibodies in autoimmune miosytis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods 2012;384:128–134.